查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1470930

胞外體研究市場：按產品/服務、適應症、應用和最終用戶 - 2024-2030 年全球預測

Exosome Research Market by Product & Service (Instruments, Kits & Reagents, Services), Indication (Cancer Indication, Cardiovascular Diseases, Infectious Diseases), Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

胞外體研究市場規模預估2023年為2.0753億美元，2024年達2.3098億美元，預估2030年將達4.5081億美元，複合年成長率為11.71%。

胞外體是幾乎所有細胞類型釋放的細胞外囊泡，存在於多種體液中，包括血液、尿液和腦脊髓液。胞外體研究市場包括胞外體分離、鑑定和分析所需的產品和服務。癌症和其他慢性疾病的迅速增加因其診斷和治療的相關性而刺激了胞外體的研究。胞外體分離和分析技術的進步正在推動市場成長。增加對生命科學研究的投資，特別是了解細胞間通訊和液態切片，正在為市場做出貢獻。然而，由於胞外體分離精製方法的標準化尚未取得進展，研究結果各不相同。區分胞外體與其他細胞外囊泡和污染物的技術困難，以及胞外體分離和分析設備的高成本，是市場面臨的挑戰。此外，擴大用於早期診斷和個人化治療策略的胞外體生物標記研究正在創造市場機會。創新和標準化胞外體分離和分析技術的開拓是這一市場潛力的主要驅動力。

主要市場統計
基準年[2023] 20753萬美元
預測年份 [2024] 23098萬美元
預測年份 [2030] 45081萬美元
複合年成長率（%） 11.71%

產品和服務 越來越關注用於診斷和治療應用的胞外體研究服務

胞外體研究設備包括用於胞外體分離和分析的各種設備，包括超速離心機、奈米顆粒追蹤分析（NTA）系統、流式細胞技術以及其他用於胞外體表徵和定量的專用設備。胞外體研究設備因其高精度、高靈敏度以及高通量高效處理樣品的能力而成為首選。胞外體研究套件和試劑包括各種用於分離、染色、追蹤和分析胞外體的預包裝溶液和化學物質。胞外體研究套件是尋求標準化且可靠的方法以確保實驗結果一致的研究人員的首選。胞外體研究服務是指為缺乏資源或專業知識來進行內部胞外體研究的研究人員提供的各種第三方服務。胞外體研究服務通常包括胞外體分離、生物標記分析、表徵和定序，這對於診斷、治療和生物標記發現應用至關重要。

觀點：癌症檢測胞外體研究的進展

用於癌症檢測的胞外體研究旨在了解胞外體在腫瘤發生、進展和轉移中的作用。胞外體攜帶特定的分子貨物，包括蛋白質和核酸，反映癌細胞的狀態，因此可作為癌症診斷和預後的潛在生物標記。心血管疾病中的胞外體研究與利用胞外體了解這些病理狀況背後的病理學過程有關。胞外體正在研究其在細胞間通訊中的作用及其調節血管生成、心臟肥大和心臟疾病發炎等過程的能力。在感染疾病背景下胞外體的研究旨在揭示它們對免疫反應和病原體傳播的影響。胞外體含有病原體和病原體衍生分子，與疾病的發展有關，為疫苗和治療方法的開發提供有用的見解。在神經退化性疾病中，胞外體研究對於了解致病蛋白傳播等疾病機制至關重要。胞外體穿過血腦障壁，為有效診斷神經系統和遞送藥物分子提供了機會。

胞外體研究在應用疫苗開發的廣泛應用

生物標記是存在於血液、體液和組織中的生物分子，是正常或異常過程或疾病狀態的標誌。胞外體穩定存在於體液中，在癌症、神經退化性疾病、心血管疾病等疾病的診斷和監測中發揮極其重要的作用。組織再生專注於受損組織和器官的修復和替換，源自於幹細胞，能夠將再生分子轉移到受損細胞中，促進癒合和再生。胞外體在免疫反應中發揮重要作用，因為它們正在被研究作為一種新型的疫苗遞送系統。胞外體可以模仿病毒顆粒並增強呈現抗原，從而有可能增強對疫苗的免疫反應。

最終用戶：將胞外體研究用於醫院和臨床環境中的診斷目的

由於學術研究機構專注於了解胞外體的生物學功能、應用和治療潛力，因此構成了胞外體研究的基礎。醫院和臨床實驗室主要出於診斷和預後目的進行胞外體研究，因為它們需要強大的、經 FDA 批准的平台和套件，以促進胞外體的準確檢測和定量，以用於患者照護。基於胞外體的藥物傳輸系統的潛力和胞外體療法的發展正在推動製藥和生物技術公司研究胞外體。製藥和生物技術公司青睞可擴展的生產方法、高純度分離技術和合規的製造流程。

區域洞察

在美洲地區，胞外體研究得到了專注於治療應用和診斷開發的公共和私人投資的支持。由於該地區主要企業的強勢地位，美國和加拿大是市場成長的主要推動力。歐盟 (EU) 國家正在透過 Horizo​​​​n Europe 等框架大力投資研究和創新，重點是加速生命科學的進步，包括胞外體研究。歐洲、中東和非洲地區的消費者需求傾向於將胞外體研究整合到全面的醫療保健解決方案中。在亞太地區，印度、日本和中國正在提高客戶對醫療保健領域新生物技術方法的參與。亞太地區已成為胞外體研究的主要中心，專利申請進展迅速。亞太地區政府對醫療保健支出的日益關注對市場成長做出了重大貢獻。

FPNV定位矩陣

FPNV定位矩陣對於評估胞外體研究市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以胞外體研究市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.胞外體研究市場的市場規模與預測為何？

2.在外胞外體研究市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.胞外體研究市場的技術趨勢和法規結構是什麼？

4.胞外體研究市場主要廠商的市場佔有率為何？

5.進入胞外體研究市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和遺傳性疾病盛行率上升
      • 擴大藥物發現和開發活動以及對有效藥物和基因遞送策略的需求
      • 推動基因組和胞外體研究的政府津貼和舉措
    • 抑制因素
      • 需要複雜精密的設備和缺乏熟練的人員
    • 機會
      • 整合先進技術，提高胞外體的效率與速度
      • 患者對個人化醫療策略的偏好
    • 任務
      • 胞外體研究的技術限制與困難
  • 市場區隔分析
    • 產品與服務：胞外體研究服務對於診斷和治療應用變得越來越重要
    • 適應症：癌症檢測胞外體研究的進展
    • 應用：胞外體研究在疫苗開發的廣泛應用
    • 最終用戶：將胞外體研究用於醫院和臨床環境中的診斷目的
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章胞外體研究市場（依產品及服務）

  • 裝置
  • 套件和試劑
  • 服務

第7章胞外體研究市場（按適應症）

  • 癌症適應症
  • 心血管疾病
  • 感染疾病
  • 神經退化性疾病

第8章胞外體研究市場：依應用分類

  • 生物標記
  • 組織再生
  • 疫苗開發

第 9 章胞外體研究市場：依最終使用者分類

  • 學術研究所
  • 醫院和臨床實驗室
  • 製藥和生物技術公司

第10章 北美和南美的胞外體研究市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區胞外體研究市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的胞外體研究市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 創新 Proteomics推出先進的胞外體分離與精製服務
    • 總部位於南卡羅來納州的 IMCS 與 Tymora Analytical 合作簡化胞外體研究
    • AGC Biologics 與慈惠醫科大學簽署胞外體協議用於特發性肺纖維化 (IPF)計劃
  • 戰略分析和建議

第14章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-AD36CD897B3A

[191 Pages Report] The Exosome Research Market size was estimated at USD 207.53 million in 2023 and expected to reach USD 230.98 million in 2024, at a CAGR 11.71% to reach USD 450.81 million by 2030.

Exosomes are extracellular vesicles released by virtually all cell types and found in various body fluids, including blood, urine, and cerebrospinal fluid. The exosome research market encompasses the products and services required to isolate, identify, and analyze exosomes. The surge in prevalence of cancer and other chronic diseases is stimulating exosome research due to its diagnostic and therapeutic relevance. The ongoing advancements in technology for isolation and analysis of exosomes is enhancing the market growth. The growing investment in life sciences research, particularly in understanding cell-to-cell communication and liquid biopsies, contributes to the market. However, lack of standardization in exosome isolation and purification methods, leading to variability in research outcomes. Technical difficulties in discriminating exosomes from other extracellular vesicles and contaminants and the high cost of exosome isolation and analysis equipment are challenging factors for the market. Moreover, the expansion of research in exosomal biomarkers for early diagnosis and personalized treatment strategies is creating opportunities in the market. The development of innovative and standardized exosome isolation and analysis techniques are significantly driving potential in the market space.

KEY MARKET STATISTICS
Base Year [2023] USD 207.53 million
Estimated Year [2024] USD 230.98 million
Forecast Year [2030] USD 450.81 million
CAGR (%) 11.71%

Product & Service: Rising emphasis on exosome research services for diagnostics and therapeutics applications

Exosome research instruments encompass the various types of hardware used to isolate and analyze exosomes, including ultracentrifuges, nanoparticle tracking analysis (NTA) systems, flow cytometry, and other specialized equipment for the characterization and quantification of exosomes. Exosome research instruments are preferred by ability to offer precision, sensitivity, and the ability to handle high-throughput samples effectively. Exosome research kits & reagents include a variety of prepackaged solutions and chemicals used in the isolation, staining, tracking, and analysis of exosomes. Exosome research kits are frequently preferred by researchers seeking standardized, reliable methodologies to ensure consistent results across experiments. The exosome research services refers to the various third-party offerings available to researchers that lack the resources or expertise to conduct certain aspects of exosome research in-house. Exosome research services typically include exosome isolation, biomarker analysis, characterization, and sequencing, which are essential for diagnostics, therapeutics, and biomarker discovery applications.

Indication: Advancements in exosome research for cancer detection

Exosome research for cancer indication is directed toward understanding the role of exosomes in tumorigenesis, progression, and metastasis. The exosomes serve as potential biomarkers for cancer diagnosis and prognosis due to the specific molecular cargo they carry, including proteins and nucleic acids that reflect the state of tumor cells. Exosome research for cardiovascular diseases is related to the use of exosomes in understanding the pathophysiological processes underlying these conditions. Exosomes are studied for their role in intercellular communication and their ability to modulate processes such as angiogenesis, cardiac hypertrophy, and inflammation in cardiac conditions. Research on exosomes in the context of infectious diseases aims to uncover the influence of the immune response and pathogen spread. Exosomes contain pathogens or pathogen-derived molecules and play a role in disease pathogenesis, providing insights that can aid vaccine and therapeutic development. In neurodegenerative diseases, exosome research is essential for understanding disease mechanisms, such as the spread of pathogenic proteins. Exosomes cross the blood-brain barrier, offering an opportunity to effectively diagnose and deliver drug molecules to the nervous system.

Application: Broad applications of exosome research for vaccine development

Biomarkers are biological molecules present in the blood, body fluids, or tissues that are sign of a normal or abnormal process or a disease condition. Exosomes have a pivotal role in disease diagnosis and monitoring, particularly for cancer, neurodegenerative, and cardiovascular diseases, owing to their stability and presence in bodily fluids. Tissue regeneration focuses on repairing or replacing damaged tissue and organs and are derived from stem cells due to their ability to transfer regenerative molecules to damaged cells, thus promoting healing and regeneration. Exosomes have a role in the immune response as they are being explored as novel delivery systems for vaccines. Exosomes can mimic virus particles, enhancing antigen presentation, and therefore can potentially boost the immune response to vaccines.

End User: Utilization of exosome research in hospitals and clinical settings for diagnostic purposes

Academic and research institutes form the foundational base for exosome research as it focuses on understanding exosome's biological functions, applications, and therapeutic potential. Hospitals and clinical testing laboratories utilize exosome research primarily for diagnostic and prognostic purposes as it requires robust, FDA-approved platforms and kits to facilitate the accurate detection and quantification of exosomes for patient care. The potential of exosome-based drug delivery systems and the development of exosome therapeutics drive the pharmaceutical and biotechnology companies in exosome research. The pharmaceutical and biotechnology entities favor scalable production methods, high-purity isolation techniques, and regulatory-compliant manufacturing processes.

Regional Insights

In the Americas region, exosome research is bolstered by both public and private investments with a significant focus on therapeutic applications and diagnostic developments. The United States and Canada are significantly bolstering the market growth by the strong position of key players operating in the region. The European Union countries invest heavily in research and innovation through frameworks such as Horizon Europe, laying an emphasis on fostering advancements in life sciences, including exosome research. Consumer needs within the EMEA region gravitate towards integrating exosome studies into comprehensive healthcare solutions. In the APAC region, India, Japan, and China are showing increasing customer engagement with novel biotechnological approaches in healthcare. The APAC region is emerging as a major hub for exosome research, displaying rapid progress in patent filings. The rising focus on healthcare spending by governments in the APAC region significantly contributes to market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Exosome Research Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Exosome Research Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Exosome Research Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Alpha Laboratories by Pace Analytical Services, AMS Biotechnology (Europe) Limited, AMSBIO, BioCat GmbH by AddLife, Creative Biolabs, Cusabio Technology LLC, Fujifilm Holdings Corporation, HiSS Diagnostics GmbH, Lonza Group Ltd., Malvern Panalytical Ltd., MBL International Corporation, Miltenyi Biotec B.V. & Co. KG, NanoSomiX, Inc., Norgen Biotek Corp., Nx Pharmagen Inc., QIAGEN N.V., System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Exosome Research Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product & Service
    • Instruments
    • Kits & Reagents
    • Services
  • Indication
    • Cancer Indication
      • Breast Cancer
      • Colorectal Cancer
      • Lung Cancer
      • Prostate Cancer
    • Cardiovascular Diseases
    • Infectious Diseases
    • Neurodegenerative Diseases
  • Application
    • Biomarkers
    • Tissue Regeneration
    • Vaccine Development
  • End User
    • Academic & Research Institutes
    • Hospitals & Clinical Testing Laboratories
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Exosome Research Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Exosome Research Market?

3. What are the technology trends and regulatory frameworks in the Exosome Research Market?

4. What is the market share of the leading vendors in the Exosome Research Market?

5. Which modes and strategic moves are suitable for entering the Exosome Research Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disease conditions and genetic disorders
      • 5.1.1.2. Expanding drug discovery and development activities and the need for efficient drug and gene delivery strategies
      • 5.1.1.3. Government grants and initiatives to advance genome and exosome research
    • 5.1.2. Restraints
      • 5.1.2.1. Need for complex and sophisticated equipment and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies to streamline and accelerate exosome research
      • 5.1.3.2. Patient preference for personalized medicine strategies
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and difficulties of exosome research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product & Service: Rising emphasis on exosome research services for diagnostics and therapeutics applications
    • 5.2.2. Indication: Advancements in exosome research for cancer detection
    • 5.2.3. Application: Broad applications of exosome research for vaccine development
    • 5.2.4. End User: Utilization of exosome research in hospitals and clinical settings for diagnostic purposes
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Exosome Research Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Kits & Reagents
  • 6.4. Services

7. Exosome Research Market, by Indication

  • 7.1. Introduction
  • 7.2. Cancer Indication
  • 7.3. Cardiovascular Diseases
  • 7.4. Infectious Diseases
  • 7.5. Neurodegenerative Diseases

8. Exosome Research Market, by Application

  • 8.1. Introduction
  • 8.2. Biomarkers
  • 8.3. Tissue Regeneration
  • 8.4. Vaccine Development

9. Exosome Research Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Clinical Testing Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Exosome Research Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Exosome Research Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Exosome Research Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Creative Proteomics Launches Advanced Exosome Isolation and Purification Service
    • 13.3.2. South Carolina-Based IMCS, Tymora Analytical Partner To Streamline Exosome Research
    • 13.3.3. AGC Biologics Signs Exosome Agreement with The Jikei University in Japan for Idiopathic Pulmonary Fibrosis (IPF) Project
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EXOSOME RESEARCH MARKET RESEARCH PROCESS
  • FIGURE 2. EXOSOME RESEARCH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EXOSOME RESEARCH MARKET DYNAMICS
  • FIGURE 7. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EXOSOME RESEARCH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. EXOSOME RESEARCH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EXOSOME RESEARCH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BIOMARKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BIOMARKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY TISSUE REGENERATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY TISSUE REGENERATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY EXOSOME RES